Caruana R J, Burkart J, Segraves D, Smallwood S, Haymore J, Disher B
Am J Nephrol. 1987;7(3):169-72. doi: 10.1159/000167458.
The mean serum amylase of 42 asymptomatic CAPD patients was elevated but was not significantly different from that of a group of chronic hemodialysis patients. Serum amylase levels in CAPD patients with peritonitis were not elevated with respect to asymptomatic patients. Amylase activity was not detectable in the peritoneal fluid of 38/42 asymptomatic patients and 6/13 peritonitis patients and was present at low levels in the other 11 patients. Patients with other abdominal conditions (pancreatitis, cholecystitis and small bowel perforation) had very marked elevations of serum and/or peritoneal fluid amylase which differentiated them from the asymptomatic and peritonitis patients. Although hyperamylasemia is common in asymptomatic CAPD patients and in those with peritonitis, measurement of serum and peritoneal fluid amylase levels is useful in the evaluation of CAPD patients presenting with abdominal symptoms.
42例无症状持续性非卧床腹膜透析（CAPD）患者的血清淀粉酶均值升高，但与一组慢性血液透析患者相比无显著差异。腹膜炎的CAPD患者血清淀粉酶水平相对于无症状患者并未升高。在42例无症状患者中的38例以及13例腹膜炎患者中的6例的腹膜液中未检测到淀粉酶活性，其他11例患者的腹膜液中淀粉酶活性处于低水平。患有其他腹部疾病（胰腺炎、胆囊炎和小肠穿孔）的患者血清和/或腹膜液淀粉酶水平显著升高，这使其与无症状和腹膜炎患者区分开来。虽然高淀粉酶血症在无症状CAPD患者和腹膜炎患者中很常见，但测定血清和腹膜液淀粉酶水平有助于评估出现腹部症状的CAPD患者。
